Literature DB >> 33620763

Orbitofrontal cortex thickness and substance use disorders in emerging adulthood: causal inferences from a co-twin control/discordant twin study.

Jeremy Harper1, Sylia Wilson2, Stephen M Malone3, Ruskin H Hunt2, Kathleen M Thomas2, William G Iacono3.   

Abstract

BACKGROUND/AIMS: Research linking orbitofrontal cortex (OFC) structure and substance use disorders (SUDs) is largely correlational and often implies a causal effect of addiction/substance exposure on the brain, but familial risk factors (e.g. genetic liability) may confound these associations. We tested whether associations between alcohol, cannabis and tobacco use disorders and OFC thickness reflected the potential causal effects of familial risk or SUDs-related consequences (e.g. substance exposure).
DESIGN: A co-twin control/discordant twin design separated familial risk confounding from SUD-related consequences. SETTING/PARTICIPANTS: A population-based sample of 436 24-year-old twins (62% monozygotic) from the Minnesota Twin Family Study, USA. MEASUREMENTS: Alcohol, cannabis and tobacco use disorders were assessed using the Composite International Diagnostic Interview-Substance Abuse Module. Cortical thickness of the medial and lateral OFC (mOFC and lOFC, respectively) was assessed using magnetic resonance imaging (MRI).
FINDINGS: Lower mOFC (P-values ≤ 0.006) but not lOFC (P-values ≥ 0.190) thickness was observed in diagnosed individuals (n = 185) relative to non-SUD controls (n = 251). Co-twin control analyses offered evidence that mOFC associations were consistent with familial risk across SUDs (between-pair effect: P-values ≤ 0.047) and the independent consequences of having an alcohol or cannabis use disorder (within-pair effect: P-values ≤ 0.024). That is, within alcohol/cannabis discordant twin pairs, affected twins had significantly lower mOFC thickness compared with their unaffected co-twins.
CONCLUSIONS: A confounder-adjusted analysis of the Minnesota Twin Family Study appeared to indicate that, beyond a substance use disorders general familial risk effect, the experience of an alcohol or cannabis use disorder in emerging adulthood reduces the thickness of the medial orbitofrontal cortex, a region associated with value-guided decision-making.
© 2021 Society for the Study of Addiction.

Entities:  

Keywords:  Addiction; alcohol; cannabis; co-twin control analysis; discordant twin design; emerging adulthood; endophenotype; orbitofrontal cortex; substance use disorders; tobacco

Mesh:

Substances:

Year:  2021        PMID: 33620763      PMCID: PMC8328872          DOI: 10.1111/add.15447

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   7.256


  52 in total

1.  Mapping cortical change across the human life span.

Authors:  Elizabeth R Sowell; Bradley S Peterson; Paul M Thompson; Suzanne E Welcome; Amy L Henkenius; Arthur W Toga
Journal:  Nat Neurosci       Date:  2003-03       Impact factor: 24.884

2.  Separation of individual-level and cluster-level covariate effects in regression analysis of correlated data.

Authors:  Melissa D Begg; Michael K Parides
Journal:  Stat Med       Date:  2003-08-30       Impact factor: 2.373

3.  Etiologic connections among substance dependence, antisocial behavior, and personality: modeling the externalizing spectrum.

Authors:  Robert F Krueger; Brian M Hicks; Christopher J Patrick; Scott R Carlson; William G Iacono; Matt McGue
Journal:  J Abnorm Psychol       Date:  2002-08

4.  An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest.

Authors:  Rahul S Desikan; Florent Ségonne; Bruce Fischl; Brian T Quinn; Bradford C Dickerson; Deborah Blacker; Randy L Buckner; Anders M Dale; R Paul Maguire; Bradley T Hyman; Marilyn S Albert; Ronald J Killiany
Journal:  Neuroimage       Date:  2006-03-10       Impact factor: 6.556

Review 5.  Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications.

Authors:  Rita Z Goldstein; Nora D Volkow
Journal:  Nat Rev Neurosci       Date:  2011-10-20       Impact factor: 34.870

6.  Dose related effects of nicotine on oxidative injury in young, adult and old rats.

Authors:  Anshu Jain; S J S Flora
Journal:  J Environ Biol       Date:  2012-03

7.  Separate or sequential exposure to nicotine prenatally and in adulthood: persistent effects on acetylcholine systems in rat brain regions.

Authors:  Theodore A Slotkin; Ian T Ryde; Frederic J Seidler
Journal:  Brain Res Bull       Date:  2007-06-04       Impact factor: 4.077

8.  Mega-Analysis of Gray Matter Volume in Substance Dependence: General and Substance-Specific Regional Effects.

Authors:  Scott Mackey; Nicholas Allgaier; Bader Chaarani; Philip Spechler; Catherine Orr; Janice Bunn; Nicholas B Allen; Nelly Alia-Klein; Albert Batalla; Sara Blaine; Samantha Brooks; Elisabeth Caparelli; Yann Ying Chye; Janna Cousijn; Alain Dagher; Sylvane Desrivieres; Sarah Feldstein-Ewing; John J Foxe; Rita Z Goldstein; Anna E Goudriaan; Mary M Heitzeg; Robert Hester; Kent Hutchison; Ozlem Korucuoglu; Chiang-Shan R Li; Edythe London; Valentina Lorenzetti; Maartje Luijten; Rocio Martin-Santos; April May; Reza Momenan; Angelica Morales; Martin P Paulus; Godfrey Pearlson; Marc-Etienne Rousseau; Betty Jo Salmeron; Renée Schluter; Lianne Schmaal; Gunter Schumann; Zsuzsika Sjoerds; Dan J Stein; Elliot A Stein; Rajita Sinha; Nadia Solowij; Susan Tapert; Anne Uhlmann; Dick Veltman; Ruth van Holst; Sarah Whittle; Margaret J Wright; Murat Yücel; Sheng Zhang; Deborah Yurgelun-Todd; Derrek P Hibar; Neda Jahanshad; Alan Evans; Paul M Thompson; David C Glahn; Patricia Conrod; Hugh Garavan
Journal:  Am J Psychiatry       Date:  2018-10-19       Impact factor: 18.112

Review 9.  Neural systems of reinforcement for drug addiction: from actions to habits to compulsion.

Authors:  Barry J Everitt; Trevor W Robbins
Journal:  Nat Neurosci       Date:  2005-11       Impact factor: 24.884

Review 10.  Do natural experiments have an important future in the study of mental disorders?

Authors:  Anita Thapar; Michael Rutter
Journal:  Psychol Med       Date:  2019-01-04       Impact factor: 7.723

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.